Helicobacter pylori
Helicobacter pylori is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
PATHOGENS
- Helicobacter pylori: attaches to gastric cells inducing inflammation and cytokine production.
- Antimicrobial effects:
- H. pylori is intrinsically resistant to sulfonamides, trimethoprim and vancomycin.
- Metronidazole resistance estimated 22-39%, 37% commonly cited in U.S. populations.
- Clarithromycin resistance ~11-12%, in some studies up to 24%.
- Amoxicillin or tetracycline resistance remains less common.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
PATHOGENS
- Helicobacter pylori: attaches to gastric cells inducing inflammation and cytokine production.
- Antimicrobial effects:
- H. pylori is intrinsically resistant to sulfonamides, trimethoprim and vancomycin.
- Metronidazole resistance estimated 22-39%, 37% commonly cited in U.S. populations.
- Clarithromycin resistance ~11-12%, in some studies up to 24%.
- Amoxicillin or tetracycline resistance remains less common.
There's more to see -- the rest of this entry is available only to subscribers.
© 2000–2022 Unbound Medicine, Inc. All rights reserved